A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Willie Earley
Allergan
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
73 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Forest Investigative Site 305
Vijayawada, Andhra Pradesh, India
- Forest Investigative Site 303
Ahmedabad, Gujarat, India
- Forest Investigative Site 308
Ahmedabad, Gujarat, India
- Forest Investigative Site 310
Ahmedabad, Gujarat, India
- Forest Investigative Site 313
Mangalore, Karnataka, India
- Forest Investigative Site 314
Manipal, Karnataka, India
- Forest Investigative Site 301
Aurangabad, Maharashtra, India
- Forest Investigative Site 306
Kalyān, Maharashtra, India
- Forest Investigative Site 311
Nashik, Maharashtra, India
- Forest Investigative Site 302
Jaipur, Rajasthan, India
- Forest Investigative Site 317
Jaipur, Rajasthan, India
- Forest Investigative Site 312
Madurai, Tamil Nadu, India
- Forest Investigative Site 309
Kanpur, Uttar Pradesh, India
- Forest Investigative Site 304
Lucknow, Uttar Pradesh, India
- Forest Investigative Site 307
Varanasi, Uttar Pradesh, India
- Forest Investigative Site 403
Bucharest, Romania
- Forest Investigative Site 405
Bucharest, Romania
- Forest Investigative Site 406
Bucharest, Romania
- Forest Investigative Site 408
Bucharest, Romania
- Forest Investigative Site 410
Bucharest, Romania
- Forest Investigative Site 407
Campulung Muscel, Romania
- Forest Investigative Site 412
Campulung Muscel, Romania
- Forest Investigative Site 402
Constanța, Romania
- Forest Investigative Site 411
Focşani, Romania
- Forest Investigative Site 401
Iași, Romania
- Forest Investigative Site 409
Iași, Romania
- Forest Investigative Site 404
Targoviste, Romania
- Forest Investigative Site 507
Bratislava, Slovakia
- Forest Investigative Site 508
Bratislava, Slovakia
- Forest Investigative Site 504
Liptovský Mikuláš, Slovakia
- Forest Investigative Site 505
Rimavská Sobota, Slovakia
- Forest Investigative Site 503
Rožňava, Slovakia
- Forest Investigative Site 506
Trnava, Slovakia
- Forest Investigative Site 609
Kerch, AR Crimea, Ukraine
- Forest Investigative Site 610
Dnipropetrovsk, Ukraine
- Forest Investigative Site 613
Donetsk, Ukraine
- Forest Investigative Site 616
Ivano-Frankivsk, Ukraine
- Forest Investigative Site 604
Kharkiv, Ukraine
- Forest Investigative Site 605
Kharkiv, Ukraine
- Forest Investigative Site 606
Kharkiv, Ukraine
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Sept 2011
- Primary completion
- 3 Sept 2014
- Completion
- 3 Sept 2014
- Last update posted
- 6 Jul 2018
- Registered enrollment
- 765
- Registry id
- NCT01412060
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.